Back
argenx SE 10K Form
Buy
60
ARGX
argenx SE
Last Price:
$631.77
Seasonality Move:
4.29%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ARGX News And Ratings
See the #1 stock for the next 7 days that we like better than ARGX
ARGX Financial Statistics
Sales & Book Value
| Annual Sales: | $1.2B |
|---|---|
| Cash Flow: | $-147M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $71.28 |
| Price / Book: | 8.87 |
Profitability
| EPS (TTM): | -0.85000 |
|---|---|
| Net Income (TTM): | $-40.3M |
| Gross Margin: | $1.1B |
| Return on Equity: | -6.01% |
| Return on Assets: | -4.89% |
argenx SE Earnings Forecast
Key argenx SE Financial Ratios
-
The Gross Profit Margin over the past 4 years for ARGX is 90.39%.
-
The Selling, General & Administrative Expenses for ARGX have been equal to 57.86% of Gross Profit Margin.
-
The Research & Development expenses have been 70.09% of Revenue.
-
The Interest Expense is -0.31% of Operating Income.
-
The Net Earning history of ARGX is -24.06% of Total Revenues.
-
Per Share Earnings over the last 13 years have been positive in 4 years.
argenx SE Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ARGX |
| CUSIP: | 04016X |
| Website: | argenx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 8.53 |
| Quick Ratio: | 7.52 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 72.16 |